Human papillomavirus (HPV) vaccine policy and evidence-based medicine: Are they at odds?

Author： Fastrez Maxime   Naik Haresh Nishan   Corfers Aurore   Rozenberg Serge  

Publisher： Informa Healthcare

ISSN： 0785-3890

Source： Annals of Medicine, Vol.44, Iss.4, 2012-06, pp. : 404-404

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Human papillomavirus (HPV) vaccine policy and evidence-based medicine: Are they at odds?

By Tomljenovic Lucija   Shaw Christopher A.  

Annals of Medicine, Vol. 45, Iss. 2, 2013-03 ,pp. : 182-193

Informa Healthcare

Access to resources Recommend Favorite

Risk, choice and the ‘girl vaccine’: Unpacking human papillomavirus (HPV) immunisation

By Mishra Amrita   Graham Janice E.  

Health, Risk & Society, Vol. 14, Iss. 1, 2012-02 ,pp. : 57-69

Routledge Ltd

Access to resources Recommend Favorite

HPV9 Vaccine for the Prevention of Human Papillomavirus–Related Cancers

By  

NURSING FOR WOMENS HEALTH, Vol. 19, Iss. 4, 2015-08 ,pp. : 365-370

John Wiley & Sons Inc

Access to resources Recommend Favorite

Focal epithelial hyperplasia by human papillomavirus (HPV)‐32 misdiagnosed as HPV‐16 and treated with combination of retinoids, imiquimod and quadrivalent HPV vaccine

By  

THE JOURNAL OF DERMATOLOGY, Vol. 42, Iss. 12, 2015-12 ,pp. : 1172-1175

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evidence-based medicine

By Smith Fang Gao   Tong Jeffrey L   Smith John E  

BJA - CEPD Reviews, Vol. 6, Iss. 4, 2006-08 ,pp. : 148-151

Oxford University Press

Access to resources Recommend Favorite